BOSTON, March 27, 2017 -- Great Elm Capital Corp. (NASDAQ:GECC) today announced plans to release its fourth quarter 2016 results on Wednesday, March 29, 2017, after the close of the financial markets.
Great Elm Capital Corp. will host a conference call at 10:00 a.m. (Eastern Time) on Thursday, March 30, 2017 to discuss its fourth quarter 2016 results.
All interested parties are invited to participate in the conference call by dialing +1 (844) 820-8297; international callers should dial +1 (661) 378-9758. Participants should enter the Conference ID 97302217 when asked. Additionally, the conference call with be webcast simultaneously at http://edge.media-server.com/m/p/b9prqagg.
An investor presentation with an appendix of supplemental schedules will accompany the conference call and be available at www.greatelmcc.com on the evening of Wednesday, March 29, 2017.
About Great Elm Capital Corp.
Great Elm Capital Corp. is an externally managed, specialty finance company focused on investing in debt instruments of middle market companies. GECC has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. GECC’s investment objective is to generate both current income and capital appreciation, while seeking to protect against risk of permanent capital loss. GECC focuses on special situations and catalyst-driven investments as it seeks attractive risk-adjusted returns.
Media & Investor Contact: Meaghan K. Mahoney Senior Vice President +1 (617) 375-3006 [email protected]


FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Trump Weighs Blocking Exxon Investment as Venezuela Deemed “Uninvestable”
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition 



